Allogene Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $717.8M
Liabilities Breakdown FY2019
Total Liabilities: $88.8M
Asset Breakdown
Total Assets: $717.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $175.1M | 24.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $56.4M | 7.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $151.0K | 0.0% |
| Other Assets | $486.1M | 67.7% |
Liabilities Breakdown
Total Liabilities: $88.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.3M | 10.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $79.5M | 89.6% |